NASDAQ:BLPH

Bellerophon Therapeutics Earning Date

USA |NASDAQ |USD

BLPH Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 3, 2021 Sep 2021 $-0.63 $-0.36 $-0.84
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 3, 2021 Sep 2021 $0.00 $0.00 $0.00

Bellerophon Therapeutics's next earnings date is Wednesday, Nov 3, 2021 for the fiscal quarter ending Sep 2021.

BLPH Earnings Date & History Chart

BLPH Earnings & Revenue Forecast

BLPH Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 2 $-0.64 $-0.68 $-0.60
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 2 $-2.22 $-2.29 $-2.15
Dec 2022 2 $-2.36 $-2.52 $-2.20

BLPH Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.67 $-0.64 $-0.64
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-2.46 $-2.59 $-2.55
Dec 2022 0 / 0 $-2.51 $-2.36 $-2.31

BLPH Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 2 $0.00 $0.00 $0.00
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 2 $0.00 $0.00 $0.00
Dec 2022 2 $3.58M $0.00 $7.16M

BLPH Earnings Date & Revenue History

BLPH Earnings History

|
Show More
Show More

BLPH Revenue History

|
Show More
Show More

Bellerophon Therapeutics Next Earnings Date & Report

BLPH Next Earnings Date & Report Preview: Sep 2021 (FQ)

BLPH's next earnings date is Wednesday, Nov 3, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 2 analysts, the average EPS estimation for Bellerophon Therapeutics's next quarterly earnings is $-0.63, with a low EPS estimation of $-0.65, and a high estimation of $-0.61.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.67, the last 2 month trend is $-0.65, and the 3 month trend is $-0.65.

Based on 3 analysts, the average revenue estimation is $0.00, with a low revenue estimation of $0.00, and a high estimation of $0.00.

Bellerophon Therapeutics Previous Earnings Dates & Reports

BLPH Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Bellerophon Therapeutics's previous earnings date was Aug 5, 2021 for its fiscal quarter ended Jun 30, 2021.

BLPH's earnings per share (EPS) was $-0.36, beating the consensus analysts forecast of $-0.62 by 41.46%.

The EPS was higher than the previous fiscal quarter (Mar 2021) by -37.93%, and higher than the same period a year before (Jun 2020) by -29.41%.

Revenues were $0.00.

The company reported a net income of $-3.39M.

Free cash flow for the quarter was $-13.26M , compared to $-7.89M last quarter and $-4.23M a year before.

BLPH ended the quarter with $728.00K in total debt, a decrease of -51.11% compared to the previous quarter, and a decrease of -63.49% compared to the same quarter a year before.

BLPH Previous Earnings Date & Report Recap: Dec 2020 (FY)

Bellerophon Therapeutics's previous annual earnings date was Mar 11, 2021 for its fiscal year ended Dec 31, 2020.

BLPH's earnings per share (EPS) was $-3.21, beating the consensus analysts forecast of $-3.34 by -3.89% , and lower than the previous year's EPS (Dec 2019) by 8.81%.

Revenues were $0.00.

The company reported a net income of $-24.73M.

Bellerophon Therapeutics reported a free cash flow of $-19.88M for its fiscal year, compared to $-12.94M a year ago.

The company ended the fiscal year with $1.66M in total debt, a decrease of -28.36% compared to the previous year.